Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS)

Sabina Beg, Krish Ragunath, Andrew Wyman, Matthew Banks, Nigel Trudgill, D Mark Pritchard, Stuart Riley, John Anderson, Helen Griffiths, Pradeep Bhandari, Phillip Kaye, Andrew Veitch, Sabina Beg, Krish Ragunath, Andrew Wyman, Matthew Banks, Nigel Trudgill, D Mark Pritchard, Stuart Riley, John Anderson, Helen Griffiths, Pradeep Bhandari, Phillip Kaye, Andrew Veitch

Abstract

This document represents the first position statement produced by the British Society of Gastroenterology and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, setting out the minimum expected standards in diagnostic upper gastrointestinal endoscopy. The need for this statement has arisen from the recognition that while technical competence can be rapidly acquired, in practice the performance of a high-quality examination is variable, with an unacceptably high rate of failure to diagnose cancer at endoscopy. The importance of detecting early neoplasia has taken on greater significance in this era of minimally invasive, organ-preserving endoscopic therapy. In this position statement we describe 38 recommendations to improve diagnostic endoscopy quality. Our goal is to emphasise practices that encourage mucosal inspection and lesion recognition, with the aim of optimising the early diagnosis of upper gastrointestinal disease and improving patient outcomes.

Keywords: OGD; early upper gastro-intestinal cancer; key performance indicators; quality.

Conflict of interest statement

Competing interests: None declared.

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Figures

Figure 1
Figure 1
Flow chart of the statement development process. OGD, oesophago-gastro-duodenoscopy; PICO, Population, Intervention, Comparator, Outcome.
Figure 2
Figure 2
A schematic demonstrating the recommended stations for photo-documentation during a diagnostic oesophago-gastro-duodenoscopy. (Reproduced with permision from Thieme [43]).

References

    1. Barrison I, Bramble M, Wilkinson M. Provision of endoscopy related services in district general hospitals: British Society of Gastroenterology. Endoscopy Committee 2001.
    1. England PH. National Cancer intelligence Network be clear on Cancer: oesophago-gastric cancer awareness regional pilot campaign: Interim evaluation report, 2015.
    1. Joint advisory group on GI endoscopy .
    1. Chadwick G, Groene O, Hoare J, et al. . A population-based, retrospective, cohort study of esophageal cancer missed at endoscopy. Endoscopy 2014;46:553–60. 10.1055/s-0034-1365646
    1. Veitch AM, Uedo N, Yao K, et al. . Optimizing early upper gastrointestinal cancer detection at endoscopy. Nat Rev Gastroenterol Hepatol 2015;12:660–7. 10.1038/nrgastro.2015.128
    1. Menon S, Trudgill N. How commonly is upper gastrointestinal Cancer missed at endoscopy? A meta-analysis. Endosc Int Open 2014;2:E46–E50. 10.1055/s-0034-1365524
    1. Chadwick G, Groene O, Riley S, et al. . Gastric cancers missed during Endoscopy in England. Clin Gastroenterol Hepatol 2015;13:1264–70. 10.1016/j.cgh.2015.01.025
    1. Bisschops R, Areia M, Coron E, et al. . Performance measures for upper gastrointestinal endoscopy: a european Society of gastrointestinal endoscopy quality improvement initiative. United European Gastroenterol J 2016;4:629–56. 10.1177/2050640616664843
    1. PLUS MA. AGREE II Instrument.
    1. Richardson WS, Wilson MC, Nishikawa J, et al. . The well-built clinical question: a key to evidence-based decisions. ACP J Club 1995;123:A12–13.
    1. Dalkey NC, Brown BB, Cochran S. The Delphi method: an experimental study of group opinion. CA: Rand Corporation Santa Monica., 1969.
    1. Veitch AM, Vanbiervliet G, Gershlick AH, et al. . Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: british Society of Gastroenterology (BSG) and european society of gastrointestinal endoscopy (ESGE) guidelines. Endoscopy 2016;48:385–402. 10.1055/s-0042-102652
    1. Council GM. Consent: patients and doctors making decisions together: general Medical Council, 2008.
    1. Shepherd H, Hewett D. Guidance for obtaining a Valid Consent for Elective Endoscopic Procedures: British Society of Gastroenterology, 2008.
    1. Clements H, Melby V. An investigation into the information obtained by patients undergoing gastroscopy investigations. J Clin Nurs 1998;7:333–42. 10.1046/j.1365-2702.1998.00161.x
    1. Mayberry MK, Mayberry JF. Towards better informed consent in endoscopy: a study of information and consent processes in gastroscopy and flexible sigmoidoscopy. Eur J Gastroenterol Hepatol 2001;13:1467–76. 10.1097/00042737-200112000-00010
    1. Toomey DP, Hackett-Brennan M, Corrigan G, et al. . Effective communication enhances the patients' endoscopy experience. Ir J Med Sci 2016;185:203–14. 10.1007/s11845-015-1270-0
    1. Levy N, Landmann L, Stermer E, et al. . Does a detailed explanation prior to gastroscopy reduce the patient’s anxiety? Endoscopy 1989;21:263–5. 10.1055/s-2007-1012965
    1. Aabakken L, Baasland I, Lygren I, et al. . Development and evaluation of written patient information for endoscopic procedures. Endoscopy 1997;29:23–6. 10.1055/s-2007-1004056
    1. Felley C, Perneger TV, Goulet I, et al. . Combined written and oral information prior to gastrointestinal endoscopy compared with oral information alone: a randomized trial. BMC Gastroenterol 2008;8:22 10.1186/1471-230X-8-22
    1. Bytzer P, Lindeberg B. Impact of an information video before colonoscopy on patient satisfaction and anxiety - a randomized trial. Endoscopy 2007;39:710–4. 10.1055/s-2007-966718
    1. Trevisani L, Sartori S, Gaudenzi P, et al. . Upper gastrointestinal endoscopy: are preparatory interventions or conscious sedation effective? A randomized trial. World J Gastroenterol 2004;10:3313–7. 10.3748/wjg.v10.i22.3313
    1. Bassi A, Brown E, Kapoor N, et al. . Dissatisfaction with consent for diagnostic gastrointestinal endoscopy. Dig Dis 2002;20:275–9. 10.1159/000067680
    1. Teh JL, Tan JR, Lau LJ, et al. . Longer examination time improves detection of gastric cancer during diagnostic upper gastrointestinal endoscopy. Clin Gastroenterol Hepatol 2015;13:e2:480–7. 10.1016/j.cgh.2014.07.059
    1. Gupta N, Gaddam S, Wani SB, et al. . Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett’s esophagus. Gastrointest Endosc 2012;76:531–8. 10.1016/j.gie.2012.04.470
    1. Shepherd HA, Bowman D, Hancock B, et al. . Postal consent for upper gastrointestinal endoscopy. Gut 2000;46:37–9. 10.1136/gut.46.1.37
    1. Sidhu R, Sakellariou V, Layte P, et al. . Patient feedback on helpfulness of postal information packs regarding informed consent for endoscopic procedures. Gastrointest Endosc 2006;64:229–34. 10.1016/j.gie.2006.02.055
    1. Lancet T. WHO’s patient-safety checklist for surgery. Lancet 2008;372:1 10.1016/S0140-6736(08)60964-2
    1. Silver SA, Thomas A, Rathe A, et al. . Development of a hemodialysis safety checklist using a structured panel process. Can J Kidney Health Dis 2015;2:39 10.1186/s40697-015-0039-8
    1. Hale G, McNab D. Developing a ward round checklist to improve patient safety. BMJ Qual Improv Rep 2015;4:u204775.w2440–w2440. 10.1136/bmjquality.u204775.w2440
    1. Matharoo M, Thomas-Gibson S, Haycock A, et al. . Implementation of an endoscopy safety checklist. Frontline Gastroenterol 2014;5:260–5. 10.1136/flgastro-2013-100393
    1. Hazelton JP, Orfe EC, Colacino AM, et al. . The impact of a multidisciplinary safety checklist on adverse procedural events during bedside bronchoscopy-guided percutaneous tracheostomy. J Trauma Acute Care Surg 2015;79:111–6. 10.1097/TA.0000000000000700
    1. Wong SS, Cleverly S, Tan KT, et al. . Impact and culture change after the implementation of a preprocedural checklist in an interventional radiology department. J Patient Saf 2015:1 10.1097/PTS.0000000000000226
    1. Matharoo M, Sevdalis N, Thillai M, et al. . The endoscopy safety checklist: A longitudinal study of factors affecting compliance in a tertiary referral centre within the United Kingdom. BMJ Qual Improv Rep 2015;4:u206344.w2567 10.1136/bmjquality.u206344.w2567
    1. Cass OW. Objective evaluation of competence: technical skills in gastrointestinal endoscopy. Endoscopy 1995;27:86–9. 10.1055/s-2007-1005640
    1. Vassiliou MC, Kaneva PA, Poulose BK, et al. . How should we establish the clinical case numbers required to achieve proficiency in flexible endoscopy? Am J Surg 2010;199:121–5. 10.1016/j.amjsurg.2009.10.004
    1. Zhang Q, Chen ZY, Chen CD, et al. . Training in early gastric cancer diagnosis improves the detection rate of early gastric cancer: an observational study in China. Medicine 2015;94:e384 10.1097/MD.0000000000000384
    1. Ooi J, Wilson P, Walker G, et al. . Dedicated Barrett’s surveillance sessions managed by trained endoscopists improve dysplasia detection rate. Endoscopy 2017;49:C1 10.1055/s-0043-109623
    1. Anagnostopoulos GK, Pick B, Cunliffe R, et al. . Barrett’s esophagus specialist clinic: what difference can it make? Dis Esophagus 2006;19:84–7. 10.1111/j.1442-2050.2006.00545.x
    1. Ginzburg S, Dar‐El EM. Skill retention and relearning – a proposed cyclical model. J Workplace Learn 2000;12:327–32. 10.1108/13665620010378822
    1. Bailey CD. Forgetting and the learning curve: a laboratory study. Manage Sci 1989;35:340–52. 10.1287/mnsc.35.3.340
    1. Perez RS, Skinner A, Weyhrauch P, et al. . Prevention of surgical skill decay. Mil Med 2013;178:76–86. 10.7205/MILMED-D-13-00216
    1. Snyder CW, Vandromme MJ, Tyra SL, et al. . Retention of colonoscopy skills after virtual reality simulator training by independent and proctored methods. Am Surg 2010;76:743–6.
    1. Chamberlain D, Smith A, Woollard M, et al. . Trials of teaching methods in basic life support (3): comparison of simulated CPR performance after first training and at 6 months, with a note on the value of re-training. Resuscitation 2002;53:179–87.
    1. Jorgensen JE, Elta GH, Stalburg CM, et al. . Do breaks in gastroenterology fellow endoscopy training result in a decrement in competency in colonoscopy? Gastrointest Endosc 2013;78:503–9. 10.1016/j.gie.2013.03.1331
    1. Rey JF, Lambert R. ESGE Quality Assurance Committee. ESGE recommendations for quality control in gastrointestinal endoscopy: guidelines for image documentation in upper and lower GI endoscopy. Endoscopy 2001;33:901–3. 10.1055/s-2001-42537
    1. Yao K. The endoscopic diagnosis of early gastric cancer. Annals of Gastroenterology 2012;26:11.
    1. Murad FM, Banerjee S, Barth BA, et al. . Image management systems. Gastrointest Endosc 2014;79:15–22. 10.1016/j.gie.2013.07.048
    1. Asl SM, Sivandzadeh GR. Efficacy of premedication with activated dimethicone or N-acetylcysteine in improving visibility during upper endoscopy. World J Gastroenterol 2011;17:4213–7. 10.3748/wjg.v17.i37.4213
    1. Kuo CH, Sheu BS, Kao AW, et al. . A defoaming agent should be used with pronase premedication to improve visibility in upper gastrointestinal endoscopy. Endoscopy 2002;34:531–4. 10.1055/s-2002-33220
    1. Chang CC, Chen SH, Lin CP, et al. . Premedication with pronase or N-acetylcysteine improves visibility during gastroendoscopy: an endoscopist-blinded, prospective, randomized study. World J Gastroenterol 2007;13:444 10.3748/wjg.v13.i3.444
    1. Neale JR, James S, Callaghan J, et al. . Premedication with N-acetylcysteine and simethicone improves mucosal visualization during gastroscopy: a randomized, controlled, endoscopist-blinded study. Eur J Gastroenterol Hepatol 2013;25:778–83. 10.1097/MEG.0b013e32836076b2
    1. Asl S, Sivandzadeh GR. Efficacy of premedication with activated dimethicone or N-acetylcysteine in improving visibility during upper endoscopy. World J Gastroenterol 2011;17:4213 10.3748/wjg.v17.i37.4213
    1. Bhandari P, Green S, Hamanaka H, et al. . Use of gascon and pronase either as a pre-endoscopic drink or as targeted endoscopic flushes to improve visibility during gastroscopy: a prospective, randomized, controlled, blinded trial. Scand J Gastroenterol 2010;45:357–61. 10.3109/00365520903483643
    1. Chang CC, Chen SH, Lin CP, et al. . Premedication with pronase or N-acetylcysteine improves visibility during gastroendoscopy: an endoscopist-blinded, prospective, randomized study. World J Gastroenterol 2007;13:444–7. 10.3748/wjg.v13.i3.444
    1. Lee SY, Han HS, Cha JM, et al. . Endoscopic flushing with pronase improves the quantity and quality of gastric biopsy: a prospective study. Endoscopy 2014;46:747–53. 10.1055/s-0034-1365811
    1. Fujii T, Iishi H, Tatsuta M, et al. . Effectiveness of premedication with pronase for improving visibility during gastroendoscopy: a randomized controlled trial. Gastrointest Endosc 1998;47:382–7. 10.1016/S0016-5107(98)70223-8
    1. Woo JG, Kim TO, Kim HJ, et al. . Determination of the optimal time for premedication with pronase, dimethylpolysiloxane, and sodium bicarbonate for upper gastrointestinal endoscopy. J Clin Gastroenterol 2013;47:389–92. 10.1097/MCG.0b013e3182758944
    1. Chen HW, Hsu HC, Hsieh TY, et al. . Pre-medication to improve esophagogastroduodenoscopic visibility: a meta-analysis and systemic review. Hepatogastroenterology 2014;61:1642–8.
    1. Inoue H, Kashida H, Kudo S, et al. . The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon. Gastrointest Endosc 2002;58(6 Suppl):S3–43.
    1. Aabakken L, Barkun AN, Cotton PB, et al. . Standardized endoscopic reporting. J Gastroenterol Hepatol 2014;29:234–40. 10.1111/jgh.12489
    1. McQuaid KR, Laine L. A systematic review and meta-analysis of randomized, controlled trials of moderate sedation for routine endoscopic procedures. Gastrointest Endosc 2008;67:910–23. 10.1016/j.gie.2007.12.046
    1. Meining A, Semmler V, Kassem AM, et al. . The effect of sedation on the quality of upper gastrointestinal endoscopy: an investigator-blinded, randomized study comparing propofol with midazolam. Endoscopy 2007;39:345–9. 10.1055/s-2006-945195
    1. NCEPOD. Scoping our practice: the 2004 Report of the National Confidential Enquiry into Patient Outcome and Death.
    1. Waring JP, Baron TH, Hirota WK, et al. . Guidelines for conscious sedation and monitoring during gastrointestinal endoscopy. Gastrointest Endosc 2003;58:317–22. 10.1067/S0016-5107(03)00001-4
    1. Riphaus A, Wehrmann T, Weber B, et al. . S3 guideline: sedation for gastrointestinal endoscopy 2008. Endoscopy 2009;41:787–815. 10.1055/s-0029-1215035
    1. Lord D, Bell G, Gray A, et al. . Sedation for gastrointestinal endoscopic procedures in the elderly: getting safer but still not nearly safe enough. The British Society of Gastroenterology Website 2006.
    1. Colleges AoMR. Safe Sedation Practice for Healthcare Procedures, 2013.
    1. Triantafillidis JK, Merikas E, Nikolakis D, et al. . Sedation in gastrointestinal endoscopy: current issues. World J Gastroenterol 2013;19:463–81. 10.3748/wjg.v19.i4.463
    1. Richter JM, Kelsey PB, Campbell EJ. Adverse event and complication management in gastrointestinal endoscopy. Am J Gastroenterol 2016;111:348–52. 10.1038/ajg.2015.423
    1. Quine MA, Bell GD, McCloy RF, et al. . Prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing, and sedation methods. Gut 1995;36:462–7. 10.1136/gut.36.3.462
    1. Prout BJ, Metreweli C. Pulmonary aspiration after fibre-endoscopy of the upper gastrointestinal tract. Br Med J 1972;4:269–71. 10.1136/bmj.4.5835.269
    1. Byrne MF, Mitchell RM, Gerke H, et al. . The need for caution with topical anesthesia during endoscopic procedures, as liberal use may result in methemoglobinemia. J Clin Gastroenterol 2004;38:225–9. 10.1097/00004836-200403000-00006
    1. Brown CM, Levy SA, Susann PW. Methemoglobinemia: life-threatening complication of endoscopy premedication. Am J Gastroenterol 1994;89:1108–9.
    1. Campo R, Brullet E, Montserrat A, et al. . Topical pharyngeal anesthesia improves tolerance of upper gastrointestinal endoscopy: a randomized double-blind study. Endoscopy 1995;27:659–64. 10.1055/s-2007-1005783
    1. Davis DE, Jones MP, Kubik CM. Topical pharyngeal anesthesia does not improve upper gastrointestinal endoscopy in conscious sedated patients. Am J Gastroenterol 1999;94:1853–6. 10.1111/j.1572-0241.1999.01217.x
    1. Lachter J, Jacobs R, Lavy A, et al. . Topical pharyngeal anesthesia for easing endoscopy: a double-blind, randomized, placebo-controlled study. Gastrointest Endosc 1990;36:19–21. 10.1016/S0016-5107(90)70915-7
    1. Froehlich F, Schwizer W, Thorens J, et al. . Conscious sedation for gastroscopy: patient tolerance and cardiorespiratory parameters. Gastroenterology 1995;108:697–704. 10.1016/0016-5085(95)90441-7
    1. Gordon MJ, Mayes GR, Meyer GW. Topical lidocaine in preendoscopic medication. Gastroenterology 1976;71:564–9.
    1. Cantor DS, Baldridge ET. Premedication with meperidine and diazepam for upper gastrointestinal endoscopy precludes the need for topical anesthesia. Gastrointest Endosc 1986;32:339–41. 10.1016/S0016-5107(86)71879-8
    1. Evans LT, Saberi S, Kim HM, et al. . Pharyngeal anesthesia during sedated EGDs: is “the spray” beneficial? A meta-analysis and systematic review. Gastrointest Endosc 2006;63:761–6. 10.1016/j.gie.2005.11.059
    1. Ristikankare M, Hartikainen J, Heikkinen M, et al. . Is routine sedation or topical pharyngeal anesthesia beneficial during upper endoscopy? Gastrointest Endosc 2004;60:686–94. 10.1016/S0016-5107(04)02048-6
    1. Sharma P, Dent J, Armstrong D, et al. . The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology 2006;131:1392–9. 10.1053/j.gastro.2006.08.032
    1. Dunn SJ, Neilson LJ, Hassan C, et al. . ESGE Survey: worldwide practice patterns amongst gastroenterologists regarding the endoscopic management of Barrett’s esophagus. Endosc Int Open 2016;4:E36–E41. 10.1055/s-0034-1393247
    1. Alvarez Herrero L, Curvers WL, van Vilsteren FG, et al. . Validation of the Prague C&m classification of Barrett’s esophagus in clinical practice. Endoscopy 2013;45:876–82. 10.1055/s-0033-1344952
    1. Fitzgerald RC, di Pietro M, Ragunath K, et al. . British Society of Gastroenterology. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut 2014;63:7–42. 10.1136/gutjnl-2013-305372
    1. Vahabzadeh B, Seetharam AB, Cook MB, et al. . Validation of the Prague C & M criteria for the endoscopic grading of Barrett’s esophagus by gastroenterology trainees: a multicenter study. Gastrointest Endosc 2012;75:236–41. 10.1016/j.gie.2011.09.017
    1. Reid BJ, Weinstein WM, Lewin KJ, et al. . Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett’s esophagus without grossly recognizable neoplastic lesions. Gastroenterology 1988;94:81–90. 10.1016/0016-5085(88)90613-0
    1. Abela JE, Going JJ, Mackenzie JF, et al. . Systematic four-quadrant biopsy detects Barrett’s dysplasia in more patients than nonsystematic biopsy. Am J Gastroenterol 2008;103:850–5. 10.1111/j.1572-0241.2007.01746.x
    1. Abrams JA, Kapel RC, Lindberg GM, et al. . Adherence to biopsy guidelines for Barrett’s esophagus surveillance in the community setting in the United States. Clin Gastroenterol Hepatol 2009;7:736–42. 10.1016/j.cgh.2008.12.027
    1. Das D, Ishaq S, Harrison R, et al. . Management of Barrett’s esophagus in the UK: overtreated and underbiopsied but improved by the introduction of a national randomized trial. Am J Gastroenterol 2008;103:1079–89. 10.1111/j.1572-0241.2008.01790.x
    1. Fitzgerald RC, Saeed IT, Khoo D, et al. . Rigorous surveillance protocol increases detection of curable cancers associated with Barrett’s esophagus. Dig Dis Sci 2001;46:1892–8. 10.1023/A:1010678913481
    1. Peters FP, Curvers WL, Rosmolen WD, et al. . Surveillance history of endoscopically treated patients with Early Barrett’s neoplasia: nonadherence to the Seattle biopsy protocol leads to sampling error. Dis Esophagus 2008;21:475–9. 10.1111/j.1442-2050
    1. Arnold M, Soerjomataram I, Ferlay J, et al. . Global incidence of oesophageal cancer by histological subtype in 2012. Gut 2015;64:381–7. 10.1136/gutjnl-2014-308124
    1. Mori M, Adachi Y, Matsushima T, et al. . Lugol staining pattern and histology of esophageal lesions. Am J Gastroenterol 1993;88:701–5.
    1. Inoue H, Rey JF, Lightdale C. Lugol chromoendoscopy for esophageal squamous cell cancer. Endoscopy 2001;33:75–9.
    1. Shimizu Y, Omori T, Yokoyama A, et al. . Endoscopic diagnosis of early squamous neoplasia of the esophagus with iodine staining: high-grade intra-epithelial neoplasia turns pink within a few minutes. J Gastroenterol Hepatol 2008;23:546–50. 10.1111/j.1440-1746.2007.04990.x
    1. Ishihara R, Yamada T, Iishi H, et al. . Quantitative analysis of the color change after iodine staining for diagnosing esophageal high-grade intraepithelial neoplasia and invasive cancer. Gastrointest Endosc 2009;69:213–8. 10.1016/j.gie.2008.04.052
    1. Dubuc J, Legoux J-, Winnock M, et al. . Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers. Endoscopy 2006;38:690–5. 10.1055/s-2006-925255
    1. Ide E, Maluf-Filho F, Chaves DM, et al. . Narrow-band imaging without magnification for detecting early esophageal squamous cell carcinoma. World J Gastroenterol 2011;17:4408–13. 10.3748/wjg.v17.i39.4408
    1. Lecleire S, Antonietti M, Iwanicki-Caron I, et al. . Lugol chromo-endoscopy versus narrow band imaging for endoscopic screening of esophageal squamous-cell carcinoma in patients with a history of cured esophageal cancer: a feasibility study. Dis Esophagus 2011;24:418–22.
    1. Chai TH, Jin XF, Li SH, et al. . A tandem trial of HD-NBI versus HD-WL to compare neoplasia miss rates in esophageal squamous cell carcinoma. Hepatogastroenterology 2014;61:120–4.
    1. Nagami Y, Tominaga K, Machida H, et al. . Usefulness of non-magnifying narrow-band imaging in screening of early esophageal squamous cell carcinoma: a prospective comparative study using propensity score matching. Am J Gastroenterol 2014;109:845–54. 10.1038/ajg.2014.94
    1. Chadwick G, Groene O, Hoare J, et al. . A population-based, retrospective, cohort study of esophageal cancer missed at endoscopy. Endoscopy 2014;46:553–60. 10.1055/s-0034-1365646
    1. Lundell LR, Dent J, Bennett JR, et al. . Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172–80. 10.1136/gut.45.2.172
    1. Akbayir N, Alkim C, Erdem L, et al. . Heterotopic gastric mucosa in the cervical esophagus (inlet patch): endoscopic prevalence, histological and clinical characteristics. J Gastroenterol Hepatol 2004;19:891–6. 10.1111/j.1440-1746.2004.03474.x
    1. Sahin G, Adas G, Koc B, et al. . Is cervical inlet patch important clinical problem? Int J Biomed Sci 2014;10:129.
    1. Maconi G, Pace F, Vago L, et al. . Prevalence and clinical features of heterotopic gastric mucosa in the upper oesophagus (inlet patch). Eur J Gastroenterol Hepatol 2000;12:745–9. 10.1097/00042737-200012070-00005
    1. Poyrazoglu OK, Bahcecioglu IH, Dagli AF, et al. . Heterotopic gastric mucosa (inlet patch): endoscopic prevalence, histopathological, demographical and clinical characteristics. Int J Clin Pract 2009;63:287–91. 10.1111/j.1742-1241.2006.01215.x
    1. Meining A, Bajbouj M, Preeg M, et al. . Argon plasma ablation of gastric inlet patches in the cervical esophagus may alleviate globus sensation: a pilot trial. Endoscopy 2006;38:566–70. 10.1055/s-2006-925362
    1. Alberty JB, Chanis R, Khoshoo V. Symptomatic gastric inlet patches in children treated with argon plasma coagulation: a case series. J Interv Gastroenterol 2012;2:91–3. 10.4161/jig.22207
    1. Bajbouj M, Becker V, Eckel F, et al. . Argon plasma coagulation of cervical heterotopic gastric mucosa as an alternative treatment for globus sensations. Gastroenterology 2009;137:440–4. 10.1053/j.gastro.2009.04.053
    1. Lauwers GY, Scott GV, Vauthey JN. Adenocarcinoma of the upper esophagus arising in cervical ectopic gastric mucosa: rare evidence of malignant potential of so-called “inlet patch”. Dig Dis Sci 1998;43:901–7. 10.1023/A:1018855223225
    1. Berkelhammer C, Bhagavan M, Templeton A, et al. . Gastric inlet patch containing submucosally infiltrating adenocarcinoma. J Clin Gastroenterol 1997;25:678–81. 10.1097/00004836-199712000-00025
    1. Mion F, Lambert R, Partensky C, et al. . High-grade dysplasia in an adenoma of the upper esophagus developing on heterotopic gastric mucosa. Endoscopy 1996;28:633–5. 10.1055/s-2007-1005561
    1. Alagozlu H, Ergun M, Cindoruk M, et al. . The rare presentations of a large polyp and an esophageal carcinoma in heterotropic gastric mucosa: a case series. J Med Case Rep 2007;1:127 10.1186/1752-1947-1-127
    1. Al-Mammari S, Selvarajah U, East JE, et al. . Narrow band imaging facilitates detection of inlet patches in the cervical oesophagus. Dig Liver Dis 2014;46:716–9. 10.1016/j.dld.2014.05.001
    1. Chung CS, Lin CK, Liang CC, et al. . Intentional examination of esophagus by narrow-band imaging endoscopy increases detection rate of cervical inlet patch. Dis Esophagus 2015;28:666–72. 10.1111/dote.12252
    1. Kohn GP, Price RR, DeMeester SR, et al. . Guidelines for the management of hiatal hernia. Surg Endosc 2013;27:4409–28. 10.1007/s00464-013-3173-3
    1. Ihde GM, Dill LA, Lister DG, et al. . A comparison of the endoscopic and laparoscopic view of the gastroesophageal junction in the use of transoral fundoplication. Am J Surg 2015;210:1018–23. 10.1016/j.amjsurg.2015.06.028
    1. Koch OO, Schurich M, Antoniou SA, et al. . Predictability of hiatal hernia/defect size: is there a correlation between pre- and intraoperative findings? Hernia 2014;18:883–8. 10.1007/s10029-012-1033-z
    1. Kahrilas PJ, Kim HC, Pandolfino JE. Approaches to the diagnosis and grading of hiatal hernia. Best Pract Res Clin Gastroenterol 2008;22:601–16. 10.1016/j.bpg.2007.12.007
    1. Liacouras CA, Furuta GT, Hirano I, et al. . Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011;128:e6:3–20. 10.1016/j.jaci.2011.02.040
    1. Dellon ES, Erichsen R, Baron JA, et al. . The increasing incidence and prevalence of eosinophilic oesophagitis outpaces changes in endoscopic and biopsy practice: national population-based estimates from Denmark. Aliment Pharmacol Ther 2015;41:662–70. 10.1111/apt.13129
    1. Prasad GA, Alexander JA, Schleck CD, et al. . Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol 2009;7:1055–61. 10.1016/j.cgh.2009.06.023
    1. Potter JW, Saeian K, Staff D, et al. . Eosinophilic esophagitis in adults: an emerging problem with unique esophageal features. Gastrointest Endosc 2004;59:355–61. 10.1016/S0016-5107(03)02713-5
    1. Croese J, Fairley SK, Masson JW, et al. . Clinical and endoscopic features of eosinophilic esophagitis in adults. Gastrointest Endosc 2003;58:516–22. 10.1067/S0016-5107(03)01870-4
    1. Baxi S, Gupta SK, Swigonski N, et al. . Clinical presentation of patients with eosinophilic inflammation of the esophagus. Gastrointest Endosc 2006;64:473–8. 10.1016/j.gie.2006.03.931
    1. Sundaram S, Sunku B, Nelson SP, et al. . Adherent white plaques: an endoscopic finding in eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2004;38:208–12. 10.1097/00005176-200402000-00020
    1. Kim HP, Vance RB, Shaheen NJ, et al. . The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol 2012;10:e5:988–96. 10.1016/j.cgh.2012.04.019
    1. Peery AF, Cao H, Dominik R, et al. . Variable reliability of endoscopic findings with white-light and narrow-band imaging for patients with suspected eosinophilic esophagitis. Clin Gastroenterol Hepatol 2011;9:475–80. 10.1016/j.cgh.2011.02.026
    1. Prasad GA, Talley NJ, Romero Y, et al. . Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol 2007;102:2627–32. 10.1111/j.1572-0241.2007.01512.x
    1. Saffari H, Peterson KA, Fang JC, et al. . Patchy eosinophil distributions in an esophagectomy specimen from a patient with eosinophilic esophagitis: implications for endoscopic biopsy. J Allergy Clin Immunol 2012;130:798–800. 10.1016/j.jaci.2012.03.009
    1. Gonsalves N, Policarpio-Nicolas M, Zhang Q, et al. . Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc 2006;64:313–9. 10.1016/j.gie.2006.04.037
    1. Shah A, Kagalwalla AF, Gonsalves N, et al. . Histopathologic variability in children with eosinophilic esophagitis. Am J Gastroenterol 2009;104:716–21. 10.1038/ajg.2008.117
    1. Yantiss RK, Odze RD. Optimal approach to obtaining mucosal biopsies for assessment of inflammatory disorders of the gastrointestinal tract. Am J Gastroenterol 2009;104:774–83. 10.1038/ajg.2008.108
    1. Furuta GT, Liacouras CA, Collins MH, et al. . Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment: sponsored by the American Gastroenterological Association (AGA) Institute and North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition. Gastroenterology 2007;133:1342–63.
    1. Tripathi D, Stanley AJ, Hayes PC, et al. . U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut 2015;64:1680–704. 10.1136/gutjnl-2015-309262
    1. Merli M, Nicolini G, Angeloni S, et al. . Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol 2003;38:266–72. 10.1016/S0168-8278(02)00420-8
    1. Grace ND, Groszmann RJ, Garcia-Tsao G, et al. . Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 1998;28:868–80. 10.1002/hep.510280339
    1. Meenan J. Staging stenotic oesophageal tumours: are CT and/or PET enough? dilate or not? Endoscopy 2006;38 Suppl 1:S8:8–12. 10.1055/s-2006-946643
    1. Lew RJ, Kochman ML. A review of endoscopic methods of esophageal dilation. J Clin Gastroenterol 2002;35:117–26. 10.1097/00004836-200208000-00001
    1. Riley SA. Guidelines on the use of oesophageal dilatation in clinical practice. Gut 2004;53(90001):1i–6. 10.1136/gut.53.suppl_1.i1
    1. Di Franco F, Lamb PJ, Karat D, et al. . Iatrogenic perforation of localized oesophageal cancer. Br J Surg 2008;95:837–9. 10.1002/bjs.6055
    1. Selinger CP, Cochrane R, Thanaraj S, et al. . Gastric ulcers: malignancy yield and risk stratification for follow-up endoscopy. Endosc Int Open 2016;4(6):A101.3–A102. 10.1055/s-0042-106959
    1. Stolte M, Seitter V, Müller H. Improvement in the quality of the endoscopic/bioptic diagnosis of gastric ulcers between 1990 and 1997--an analysis of 1,658 patients. Z Gastroenterol 2001;39:349–55. 10.1055/s-2001-13709
    1. Graham DY, Lew GM, Klein PD, et al. . Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992;116:705–8.
    1. Mountford RA, Brown P, Salmon PR, et al. . Gastric cancer detection in gastric ulcer disease. Gut 1980;21:9–17. 10.1136/gut.21.1.9
    1. Lupano F, Sategna-Guidetti C. Endoscopic follow-up of patients with gastric ulcer. A prospective study. J Clin Gastroenterol 1986;8:430–4.
    1. Hopper AN, Stephens MR, Lewis WG, et al. . Relative value of repeat gastric ulcer surveillance gastroscopy in diagnosing gastric cancer. Gastric Cancer 2006;9:217–22. 10.1007/s10120-006-0385-4
    1. Yeh JM, Ho W, Hur C. Cost-effectiveness of endoscopic surveillance of gastric ulcers to improve survival. Gastrointest Endosc 2010;72:33–43. 10.1016/j.gie.2010.01.047
    1. Llanos O, Guzmán S, Duarte I. Accuracy of the first endoscopic procedure in the differential diagnosis of gastric lesions. Ann Surg 1982;195:224–6. 10.1097/00000658-198202000-00018
    1. Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis 2012;13:2–9. 10.1111/j.1751-2980.2011.00550.x
    1. Correa P, Haenszel W, Cuello C, et al. . A model for gastric cancer epidemiology. Lancet 1975;2:58–60. 10.1016/S0140-6736(75)90498-5
    1. Dinis-Ribeiro M, Areia M, de Vries AC, et al. . Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Virchows Arch 2012;460:19–46. 10.1007/s00428-011-1177-8
    1. Kuipers EJ, Peña AS, Festen HPM, et al. . Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995;345:1525–8. 10.1016/S0140-6736(95)91084-0
    1. Ohata H, Kitauchi S, Yoshimura N, et al. . Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004;109:138–43. 10.1002/ijc.11680
    1. Zhou L, Sung JJ, Lin S, et al. . A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication. Chin Med J 2003;116:11–14.
    1. Wang J, Xu L, Shi R, et al. . Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis. Digestion 2011;83:253–60. 10.1159/000280318
    1. Lee TY, Wang RC, Lee YC, et al. . The incidence of gastric adenocarcinoma among patients with gastric intestinal metaplasia: a long-term cohort study. J Clin Gastroenterol 2016;50:532–7. 10.1097/MCG.0000000000000406
    1. Whiting JL, Sigurdsson A, Rowlands DC, et al. . The long term results of endoscopic surveillance of premalignant gastric lesions. Gut 2002;50:378–81. 10.1136/gut.50.3.378
    1. Hosking SW, Ling TK, Chung SC, et al. . Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet 1994;343:508–10. 10.1016/S0140-6736(94)91460-5
    1. Rauws EA, Tytgat GN. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990;335:1233–5. 10.1016/0140-6736(90)91301-P
    1. Forbes GM, Glaser ME, Cullen DJ, et al. . Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet 1994;343:258–60. 10.1016/S0140-6736(94)91111-8
    1. Lanza FL, Chan FK, Quigley EM. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 2009;104:728–38. 10.1038/ajg.2009.115
    1. Hawkey CJ. Non-steroidal anti-inflammatory drugs and peptic ulcers. BMJ 1990;300:278–84. 10.1136/bmj.300.6720.278
    1. Stolte M, Sticht T, Eidt S, et al. . Frequency, location, and age and sex distribution of various types of gastric polyp. Endoscopy 1994;26:659–65. 10.1055/s-2007-1009061
    1. Carmack SW, Genta RM, Schuler CM, et al. . The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol 2009;104:1524–32. 10.1038/ajg.2009.139
    1. Morais DJ, Yamanaka A, Zeitune JM, et al. . Gastric polyps: a retrospective analysis of 26,000 digestive endoscopies. Arq Gastroenterol 2007;44:14–17. 10.1590/S0004-28032007000100004
    1. Weston BR, Helper DJ, Rex DK. Positive predictive value of endoscopic features deemed typical of gastric fundic gland polyps. J Clin Gastroenterol 2003;36:399–402. 10.1097/00004836-200305000-00007
    1. Goddard AF, Badreldin R, Pritchard DM, et al. . The management of gastric polyps. Gut 2010;59:1270–6. 10.1136/gut.2009.182089
    1. Muehldorfer SM, Stolte M, Martus P, et al. . Diagnostic accuracy of forceps biopsy versus polypectomy for gastric polyps: a prospective multicentre study. Gut 2002;50:465–70. 10.1136/gut.50.4.465
    1. Deppisch LM, Rona VT. Gastric epithelial polyps. A 10-year study. J Clin Gastroenterol 1989;11:110–5.
    1. Vasen HF, Möslein G, Alonso A, et al. . Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 2008;57:704–13. 10.1136/gut.2007.136127
    1. Ngamruengphong S, Boardman LA, Heigh RI, et al. . Gastric adenomas in familial adenomatous polyposis are common, but subtle, and have a benign course. Hered Cancer Clin Pract 2014;12:4 10.1186/1897-4287-12-4
    1. Barada K, Habib RH, Malli A, et al. . Prediction of celiac disease at endoscopy. Endoscopy 2014;46:110–9. 10.1055/s-0033-1359200
    1. Brocchi E, Tomassetti P, Misitano B, et al. . Endoscopic markers in adult coeliac disease. Dig Liver Dis 2002;34:177–82. 10.1016/S1590-8658(02)80190-6
    1. Oxentenko AS, Grisolano SW, Murray JA, et al. . The insensitivity of endoscopic markers in celiac disease. Am J Gastroenterol 2002;97:933–8. 10.1111/j.1572-0241.2002.05612.x
    1. Dickey W, Hughes D. Disappointing sensitivity of endoscopic markers for villous atrophy in a high-risk population: implications for celiac disease diagnosis during routine endoscopy. Am J Gastroenterol 2001;96:2126–8. 10.1111/j.1572-0241.2001.03947.x
    1. Evans KE, Aziz I, Cross SS, et al. . A prospective study of duodenal bulb biopsy in newly diagnosed and established adult celiac disease. Am J Gastroenterol 2011;106:1837–42. 10.1038/ajg.2011.171
    1. Lebwohl B, Kapel RC, Neugut AI, et al. . Adherence to biopsy guidelines increases celiac disease diagnosis. Gastrointest Endosc 2011;74:103–9. 10.1016/j.gie.2011.03.1236
    1. Ludvigsson JF, Bai JC, Biagi F, et al. . Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut 2014;63:1210–28. 10.1136/gutjnl-2013-306578
    1. Hopper AD, Sanders DS. Obtaining duodenal biopsy specimens for celiac disease: is site as important as number? Gastrointest Endosc 2009;69:389–90. 10.1016/j.gie.2008.06.041
    1. Pais WP, Duerksen DR, Pettigrew NM, et al. . How many duodenal biopsy specimens are required to make a diagnosis of celiac disease? Gastrointest Endosc 2008;67:1082–7. 10.1016/j.gie.2007.10.015
    1. Jones HJ, Warner JT. NICE clinical guideline 86. Coeliac disease: recognition and assessment of coeliac disease. Arch Dis Child 2010;95:312–3. 10.1136/adc.2009.173849
    1. Lal N, Bhasin DK, Malik AK, et al. . Optimal number of biopsy specimens in the diagnosis of carcinoma of the oesophagus. Gut 1992;33:724–6. 10.1136/gut.33.6.724
    1. Graham DY, Schwartz JT, Cain GD, et al. . Prospective evaluation of biopsy number in the diagnosis of esophageal and gastric carcinoma. Gastroenterology 1982;82:228–31.
    1. Gravalos C, Jimeno A. HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol 2008;19:1523–9. 10.1093/annonc/mdn169
    1. Bang YJ, Van Cutsem E, Feyereislova A, et al. . ToGA Trial Investigators. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010;376:687–97. 10.1016/S0140-6736(10)61121-X
    1. Hofmann M, Stoss O, Shi D, et al. . Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology 2008;52:797–805. 10.1111/j.1365-2559.2008.03028.x
    1. Bretthauer M, Aabakken L, Dekker E, et al. . Requirements and standards facilitating quality improvement for reporting systems in gastrointestinal endoscopy: European Society of gastrointestinal endoscopy (ESGE) position statement. Endoscopy 2016;48:291–4. 10.1055/s-0042-100186
    1. Delvaux M, Korman LY, Armengol-Miro JR, et al. . The minimal standard terminology for digestive endoscopy: introduction to structured reporting. Int J Med Inform 1998;48:217–25. 10.1016/S1386-5056(97)00128-7
    1. Beaulieu D, Barkun AN, Dubé C, et al. . Endoscopy reporting standards. Can J Gastroenterol 2013;27:286–92. 10.1155/2013/145894
    1. Yalamarthi S, Witherspoon P, McCole D, et al. . Missed diagnoses in patients with upper gastrointestinal cancers. Endoscopy 2004;36:874–9. 10.1055/s-2004-825853
    1. Raftopoulos SC, Segarajasingam DS, Burke V, et al. . A cohort study of missed and new cancers after esophagogastroduodenoscopy. Am J Gastroenterol 2010;105:1292–7. 10.1038/ajg.2009.736
    1. Voutilainen ME, Juhola MT. Evaluation of the diagnostic accuracy of gastroscopy to detect gastric tumours: clinicopathological features and prognosis of patients with gastric cancer missed on endoscopy. Eur J Gastroenterol Hepatol 2005;17:1345–9. 10.1097/00042737-200512000-00013
    1. Amin A, Gilmour H, Graham L, et al. . Gastric adenocarcinoma missed at endoscopy. J R Coll Surg Edinb 2002;47:681–4.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit